MOG and myeloid sarcoma: BN rats also have a strong anti‐MOG antibody response (Stefferl et al., 1999), which may also demonstrate the relevance of this model for other neurological diseases such as pediatric MS, subgroups of neuromyelitis optica and cases of anti‐NMDA‐receptor encephalitis where such antibodies are present (Havla et al., 2017).